Odonate Therapeutics, Inc. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7f64226e-c0c2-4462-8208-025767958f07/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-127.4M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-007296 |
| FY 2019 | $-114.9M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-005407 |
| FY 2018 | $-90.8M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-003806 |
| FY 2017 | $-32.7M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-003806 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).